Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News VIVA 2020

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

L.A. McKeown

November 27, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

Presentation TCT 2020

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Presenter: Fernando Alfonso

October 15, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

Presentation TCT 2020

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

Presenter: Jian Tian

October 14, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

June 26, 2020

News

Drug-Coated Balloons for CAD: Some International Consensus

L.A. McKeown

May 27, 2020

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

L.A. McKeown

May 14, 2020

Podcast TCTMD Talking Points

Onyx ONE: Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

April 15, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

Presentation JIM 2020

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

Presenter: Bernardo Cortese

February 13, 2020

News Conference News LINC 2020

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

L.A. McKeown

January 28, 2020

Advertisement

As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

TCT 257: Drug-Coated Balloon Versus Drug-Eluting Stent for the Treatment of Small Vessel Disease: 3-Year Clinical Outcomes of the RESTORE SVD China Randomized Trial

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

Drug-Coated Balloons for CAD: Some International Consensus

Recovered Paclitaxel PAD Data Shift the Mortality Picture

Onyx ONE: Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content